Pharmacy
Enrollees in high-need areas often lack access to providers who can prescribe or dispense these medications, OIG finds.
There is a shift from treating a disease to preventing it, says PhRMA chief medical officer Dr. Mike Ybarra.
Prices for 25 drugs are expected to decrease for Medicare beneficiaries starting in 2026 and continuing into 2027.
The drugmaker says it believes the rebate model is legally permissible and needed to improve the integrity of the 340B program.
The rebates paid by drug companies will be deposited into the Medicare Trust Fund.
The lower MA premiums are expected to drive enrollment to 35.7 million by 2025 - about 51% of all Medicare beneficiaries.
HHS is offering the tests to help prevent widespread infections this fall and winter.
Resistant infections result in more than 35,000 deaths each year and cost the health system billions.
Insurance companies and PBMs set the price of drugs paid at the pharmacy counter, says CEO Lars Fruergaard Jørgensen.
Caremark, Express Scripts, Optum and their GPOs created a rebate system that boosted PBM profits, FTC alleges.